Antibiotic Dosage Recommendations for Pediatric Upper Respiratory Tract Infections

General Dosing Principles for Common URTIs

The American Academy of Otolaryngology-Head and Neck Surgery recommends the use of amoxicillin at 45 mg/kg/day divided into two doses or 40 mg/kg/day divided into three doses for mild to moderate infections, with higher dosing of 90 mg/kg/day for more severe infections or when drug-resistant pathogens are suspected 1, 2
For acute otitis media, amoxicillin is the first-line treatment at 40 mg/kg/day in divided doses twice daily for 5 days 2
For patients who have received antibiotics in the previous 4-6 weeks, high-dose amoxicillin (90 mg/kg/day) should be used 1, 3
In areas with high prevalence of penicillin-resistant S. pneumoniae, high-dose amoxicillin/clavulanate (90 mg/6.4 mg per kg per day) is recommended 3

For children 3 months to 5 years, amoxicillin 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours is recommended 1
For pneumonia in children under 3 years, amoxicillin 80-100 mg/kg/day in three daily doses is recommended 4

For acute otitis media, treatment duration should be 5 days for uncomplicated cases 2
For acute bacterial rhinosinusitis, treatment duration should be 5-8 days 4

The American Academy of Otolaryngology-Head and Neck Surgery recommends assessing for recent antibiotic use within 4-6 weeks, as this increases risk of resistant organisms and should guide therapy selection 1, 3
Evaluating response to therapy at 72 hours is recommended, as lack of improvement may indicate treatment failure requiring change in antibiotic or reevaluation 1, 3
High-dose amoxicillin regimens are preferred in areas with high prevalence of drug-resistant S. pneumoniae 1, 3
For beta-lactam allergic patients, alternatives include TMP/SMX, macrolides, or clindamycin, though these have lower efficacy against common URTI pathogens 3

The American Thoracic Society recommends Amoxicillin as the first-line treatment for children under 5 years with suspected bacterial URTI because it is effective against the majority of pathogens, well-tolerated, and cost-effective 5, 6

For areas with high prevalence of penicillin-resistant S. pneumoniae, or for children with insufficient vaccination against H. influenzae type b or coexistent purulent acute otitis media, the European Society of Clinical Microbiology and Infectious Diseases suggests considering amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component) 7

The American Thoracic Society advises that the child should be reviewed if deteriorating or not improving after 48 hours on treatment, and families need information on managing fever, preventing dehydration, and identifying any signs of deterioration 5, 6

For areas with high prevalence of penicillin-resistant S. pneumoniae: High-dose amoxicillin (90 mg/kg/day) is recommended, as suggested by the American Academy of Pediatrics 8
For children under 3 years with suspected bacterial pneumonia: 80-100 mg/kg/day in three daily doses is recommended, according to the European Society of Clinical Microbiology and Infectious Diseases 9

For children over 5 years: Similar dosing as younger children, but with attention to maximum daily doses, as recommended by the Infectious Diseases Society of America 10

For streptococcal pharyngitis: Amoxicillin 50-75 mg/kg/day in 2 doses for 10 days is recommended, as suggested by the Infectious Diseases Society of America 11

Evaluate response to therapy after 48-72 hours; lack of improvement may indicate treatment failure requiring change in antibiotic or reevaluation, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 9
The American Academy of Pediatrics recommends judicious use of antibiotics to prevent the development of antibiotic resistance 8